Company: DMAC
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001437749-25-034467
Chunk: 1

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01

Financial Statements and Exhibits.

  (d)      Exhibits.  

  Exhibit No.      Description                                                                                                                                 
         99.1      Press Release dated November 12, 2025 providing a business update and announcing third quarter 2025 financial results (furnished herewith)  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      The cover page from this Current Report on Form 8-K, formatted in Inline XBRL                                                               

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  DIAMEDICA THERAPEUTICS INC.                                             
  By:                              /s/ Scott Kellen                       
                                   Scott Kellen                           
                                   Chief Financial Officer and Secretary  

Dated:November 12, 2025